Specific triggers for medical consultation include achieving less than 5% body weight reduction after reaching the maintenance dose (for Wegovy, after 12 weeks at 2.4 mg as per FDA labeling), prolonged weight loss plateau despite adherence, or intolerable side effects preventing dose escalation to therapeutic levels
Patients are often told to think in extremes:either medication is the answer, or medication is somehow cheating. Neither framing is very helpful
Rex MD has a low rating on the BBB with numerous complaints about refunds, slow delivery time, and poor customer service
This can vary by plan, so always check your specific policy documents
If the manufacturer wins the patent challenge, generic semaglutide could enter the market years earlier than the patent expiration dates listed above
It requires documented lifestyle program participation, maintenance-dose attestations, and at least 5% weight-loss maintenance for reauthorization